Home/Exo Therapeutics/Kevin Leach, Ph.D., DABT

KL

Kevin Leach, Ph.D., DABT

Senior Drug Development Advisor

Exo Therapeutics

Therapeutic Areas

Oncology Inflammation

Exo Therapeutics Pipeline

Drug	Indication	Phase
EXO-TBKi	Inflammatory diseases (via STING pathway/TBK1 inhibition)	Pre-clinical

Leadership Team at Exo Therapeutics

Alan Saghatelian, PhD

Ronenn Roubenoff, MD

Senior Clinical Advisor

Dave Guerin, Ph.D.

Senior Medicinal Chemistry Advisor

View full Exo Therapeutics profile